Ask AI
Barriers to Optimizing ART

CE / CME

Overcoming Fear of Virologic Failure: Barriers to Optimizing ART in People With HIV and Viral Suppression

Pharmacists: 0.25 contact hour (0.025 CEUs)

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: October 09, 2025

Expiration: October 08, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

In someone with durable viral suppression and no known history of virologic failure or resistance, if switching to a guideline-recommended regimen, the risk of virologic failure is so low that it should not be a barrier to the decision to change regimens.

2.

Across observational cohorts of adults with virological suppression, switching to LA cabotegravir + rilpivirine was associated with confirmed virologic failure rates of: